Literature DB >> 8498497

Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes.

P Nuutila1, J Knuuti, U Ruotsalainen, V A Koivisto, E Eronen, M Teräs, J Bergman, M Haaparanta, L M Voipio-Pulkki, J Viikari.   

Abstract

To determine the tissue localization of insulin resistance in type 1 diabetic patients, whole body and regional glucose uptake rates were determined under euglycemic hyperinsulinemic conditions. Leg, arm, and heart glucose uptake rates were measured using positron emission tomography-derived 2-deoxy-2-[18F]-fluoro-D-glucose kinetics and the three-compartment model described by Sokoloff et al. (L. Sokoloff, M. Reivich, C. Kennedy, M.C. DesRosiers, C.S. Patlak, K.D. Pettigrew, O. Sakurada, and M. Shinohara. J. Neurochem. 28: 897-916, 1977) in eight type 1 diabetic patients and eight matched normal subjects. Whole body glucose uptake was quantitated by the euglycemic insulin clamp technique. Whole body glucose uptake was approximately 31% lower in the diabetic patients (P < 0.01) than in the normal subjects, thus confirming the presence of whole body insulin resistance. The rate of glucose uptake was approximately 45% lower in leg muscle when measured in the femoral region (55 +/- 7 vs. 102 +/- 13 mumol.kg muscle-1.min-1, diabetic patients vs. normal subjects, P < 0.05) and approximately 27% lower in the arm muscles (66 +/- 4 vs. 90 +/- 13 mumol.kg muscle-1.min-1, respectively, P < 0.05), whereas no difference was observed in heart glucose uptake [789 +/- 80 vs. 763 +/- 58 mumol.kg muscle-1.min-1 not significant (NS)]. Whole body glucose uptake correlated with glucose uptake in femoral (r = 0.93, P < 0.005) and arm muscles (r = 0.66, P < 0.05) but not with glucose uptake in the heart (r = 0.04, NS). We conclude that insulin resistance in type 1 diabetic patients is localized to skeletal muscle, whereas heart glucose uptake is unaffected.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8498497     DOI: 10.1152/ajpendo.1993.264.5.E756

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Myocardial insulin resistance in patients with syndrome X.

Authors:  H E Botker; N Moller; O Schmitz; J P Bagger; T T Nielsen
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 2.  Role of insulin resistance in the pathogenesis of NIDDM.

Authors:  H Yki-Järvinen
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

3.  Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.

Authors:  G Paternostro; P G Camici; A A Lammerstma; N Marinho; R R Baliga; J S Kooner; G K Radda; E Ferrannini
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

4.  Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose.

Authors:  H E Bøtker; M Böttcher; O Schmitz; A Gee; S B Hansen; G E Cold; T T Nielsen; A Gjedde
Journal:  J Nucl Cardiol       Date:  1997 Mar-Apr       Impact factor: 5.952

5.  Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle.

Authors:  P Nuutila; M J Knuuti; O J Heinonen; U Ruotsalainen; M Teräs; J Bergman; O Solin; H Yki-Järvinen; L M Voipio-Pulkki; U Wegelius
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 6.  Beta-blockers after acute myocardial infarction in elderly patients with diabetes mellitus: time to reassess.

Authors:  Mauro Di Bari; Niccolò Marchionni; Marco Pahor
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

7.  Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomography.

Authors:  P Nuutila; M Raitakari; H Laine; O Kirvelä; T Takala; T Utriainen; S Mäkimattila; O P Pitkänen; U Ruotsalainen; H Iida; J Knuuti; H Yki-Järvinen
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

8.  Myocardial glucose utilisation in type II diabetes mellitus patients treated with sulphonylurea drugs.

Authors:  Ikuo Yokoyama; Yusuke Inoue; Toshiyuki Moritan; Kuni Ohtomo; Ryozo Nagai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-10       Impact factor: 9.236

Review 9.  Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications.

Authors:  Samantha K Coleman; Irena A Rebalka; Donna M D'Souza; Thomas J Hawke
Journal:  World J Diabetes       Date:  2015-12-10

10.  Insulin action on heart and skeletal muscle glucose uptake in essential hypertension.

Authors:  P Nuutila; M Mäki; H Laine; M J Knuuti; U Ruotsalainen; M Luotolahti; M Haaparanta; O Solin; A Jula; V A Koivisto
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.